• Completion of 80-patient Phase 3 trial (data expected in Q4 2019) to drive clinical unit sales • First clinical unit sales expected in H2 2020 • Currently selling units to research institutions • Scope for potential partnerships with big pharma in the near-term
22 Jul 2019
Nearing pivotal trial completion
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Nearing pivotal trial completion
Polarean Imaging Plc (POLX:LON) | 3.9 0 0.0% | Mkt Cap: 8.43m
- Published:
22 Jul 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
35
• Completion of 80-patient Phase 3 trial (data expected in Q4 2019) to drive clinical unit sales • First clinical unit sales expected in H2 2020 • Currently selling units to research institutions • Scope for potential partnerships with big pharma in the near-term